Literature DB >> 7723774

Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chains.

K M Keating1, D B Segal, S J Craig, A K Nault, V Semensi, A S Wasserman, C M Counsell, J F Bond.   

Abstract

In this study we have addressed the question of whether reassociating the two recombinant protein chains that comprise the major cat dander allergen, Fel d I, would change the overall IgE and allergic patient T cell immunoreactivity compared to the native molecule. To accomplish this, the chains were combined under reducing and denaturing conditions, then allowed to reassociate by dilution and extensive dialysis against a physiological buffer. An initial examination of the reaction products using quantitative capture ELISA demonstrated comparable reactivity to Fel d I. Further analysis, using a pool of cat allergic patient plasma, showed that the products of the reassociation reaction (rFel d I) also possessed an enhanced IgE binding capacity. Depletion ELISA results gave only a 5% difference in reactivity between rFel d I and the native protein versus a 20% difference with the mixture of the two chains. Comparative secondary T cell stimulation assays were subsequently performed using cat allergic patient peripheral blood lymphocytes. Here the results demonstrated no loss of reactivity with the reassociated chains as compared to Fel d I or the two mixed recombinant chains. To biochemically characterize the products of the reassociation reaction we have performed reverse phase HPLC and then analysed the isolated fractions by mass spectrometry. It was clear from these results that like the native Fel d I, the products of the reassociation reaction favored heterodimer formation, with no homodimer being detected. This implies that the reassociated protein chains had preferentially adopted a native-like conformation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723774     DOI: 10.1016/0161-5890(94)00140-v

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

Review 1.  Recombinant allergens.

Authors:  C Grégoire; M D Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

2.  Fel d 1-airway inflammation prevention and treatment by co-immunization vaccine via induction of CD4+CD25-Foxp3+ Treg cells.

Authors:  Yechun Pei; Shuang Geng; Lin Liu; Fengxiang Yan; Hong Guan; Jian Hou; Yongfu Chen; Bin Wang; Xiaorong An
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

3.  Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity.

Authors:  Serge A Versteeg; Ingrid Bulder; Martin Himly; Toni M van Capel; R van den Hout; Stef J Koppelman; Esther C de Jong; Fatima Ferreira; Ronald van Ree
Journal:  World Allergy Organ J       Date:  2011-07-14       Impact factor: 4.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.